{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:46:01Z","timestamp":1782873961877,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Scholarship Council, China"},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joriss\/ENS research program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01487-4","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:04:46Z","timestamp":1778223886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An ERR\u03b1-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers"],"prefix":"10.1186","volume":"32","author":[{"given":"Jing-Ru","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Poulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cerutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tr\u00e9dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Le Romancer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Liu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Vanacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"1487_CR1","doi-asserted-by":"publisher","first-page":"13093","DOI":"10.3390\/ijms241713093","volume":"24","author":"R Aiyappa-Maudsley","year":"2023","unstructured":"Aiyappa-Maudsley R, McLoughlin LFV, Hughes TA. Semaphorins and their roles in breast cancer: implications for therapy resistance. Int J Mol Sci. 2023;24:13093.","journal-title":"Int J Mol Sci"},{"key":"1487_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/aps.2014.121","volume":"36","author":"E Audet-Walsh","year":"2015","unstructured":"Audet-Walsh E, Gigu\u00e8re V. The multiple universes of estrogen-related receptor \u03b1 and \u03b3 in metabolic control and related diseases. Acta Pharmacol Sin. 2015;36:51\u201361.","journal-title":"Acta Pharmacol Sin"},{"key":"1487_CR3","doi-asserted-by":"publisher","first-page":"23286","DOI":"10.1074\/jbc.M109.028191","volume":"284","author":"S Bianco","year":"2009","unstructured":"Bianco S, Lanvin O, Tribollet V, Macari C, North S, Vanacker JM. Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J Biol Chem. 2009;284:23286\u201392.","journal-title":"J Biol Chem"},{"key":"1487_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jsbmb.2011.03.014","volume":"130","author":"S Bianco","year":"2012","unstructured":"Bianco S, Sailland J, Vanacker JM. ERRs and cancers: effects on metabolism and on proliferation and migration capacities. J Steroid Biochem Mol Biol. 2012;130:180\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1487_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/emboj.2010.349","volume":"30","author":"S Brabletz","year":"2011","unstructured":"Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, et al. The ZEB1\/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 2011;30:770\u201382.","journal-title":"EMBO J"},{"key":"1487_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/embor.2008.74","volume":"9","author":"U Burk","year":"2008","unstructured":"Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008;9:582\u20139.","journal-title":"EMBO Rep"},{"key":"1487_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/0008-5472.CAN-17-2476","volume":"78","author":"J Caramel","year":"2018","unstructured":"Caramel J, Ligier M, Puisieux A. Pleiotropic Roles for ZEB1 in Cancer. Cancer Res. 2018;78:30\u20135.","journal-title":"Cancer Res"},{"key":"1487_CR8","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1073\/pnas.1614664114","volume":"114","author":"J Carnesecchi","year":"2017","unstructured":"Carnesecchi J, Forcet C, Zhang L, Tribollet V, Barenton B, Boudra R, et al. ERR\u03b1 induces H3K9 demethylation by LSD1 to promote cell invasion. Proc Natl Acad Sci U S A. 2017a;114:3909\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1487_CR9","doi-asserted-by":"publisher","first-page":"e0188871","DOI":"10.1371\/journal.pone.0188871","volume":"12","author":"J Carnesecchi","year":"2017","unstructured":"Carnesecchi J, Cerutti C, Vanacker JM, Forcet C. ERR\u03b1 protein is stabilized by LSD1 in a demethylation-independent manner. PLoS ONE. 2017b;12:e0188871.","journal-title":"PLoS ONE"},{"key":"1487_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1210\/me.2005-0227","volume":"20","author":"A Castet","year":"2006","unstructured":"Castet A, Herledan A, Bonnet S, Jalaguier S, Vanacker JM, Cavaill\u00e8s V. Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol Endocrinol. 2006;20:1035\u201347.","journal-title":"Mol Endocrinol"},{"key":"1487_CR11","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1038\/s41598-022-07744-w","volume":"12","author":"C Cerutti","year":"2022","unstructured":"Cerutti C, Zhang L, Tribollet V, Shi JR, Brillet R, Gillet B, et al. Computational identification of new potential transcriptional partners of ERR\u03b1 in breast cancer cells: specific partners for specific targets. Sci Rep. 2022;12:3826.","journal-title":"Sci Rep"},{"key":"1487_CR12","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.3390\/ijms24054265","volume":"24","author":"C Cerutti","year":"2023","unstructured":"Cerutti C, Shi JR, Vanacker JM. Multifaceted transcriptional network of estrogen-related receptor alpha in health and disease. Int J Mol Sci. 2023;24:4265.","journal-title":"Int J Mol Sci"},{"key":"1487_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fbioe.2020.00220","volume":"8","author":"P Chakraborty","year":"2020","unstructured":"Chakraborty P, George JT, Tripathi S, Levine H, Jolly MK. Comparative study of transcriptomics-based scoring metrics for the epithelial-hybrid-mesenchymal spectrum. Front Bioeng Biotechnol. 2020;8:220.","journal-title":"Front Bioeng Biotechnol"},{"key":"1487_CR14","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1038\/s41388-024-03078-1","volume":"43","author":"W Chen","year":"2024","unstructured":"Chen W, Song YS, Lee HS, Lin CW, Lee J, Kang YE, et al. Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Oncogene. 2024;43:2431\u201346.","journal-title":"Oncogene"},{"key":"1487_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mce.2013.04.006","volume":"380","author":"Y Chinenov","year":"2013","unstructured":"Chinenov Y, Gupte R, Rogatsky I. Nuclear receptors in inflammation control: repression by GR and beyond. Mol Cell Endocrinol. 2013;380:55\u201364.","journal-title":"Mol Cell Endocrinol"},{"key":"1487_CR16","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.15252\/embj.201797345","volume":"36","author":"M Cort\u00e9s","year":"2017","unstructured":"Cort\u00e9s M, Sanchez-Moral L, de Barrios O, Fern\u00e1ndez-Ace\u00f1ero MJ, Mart\u00ednez-Campanario MC, Esteve-Codina A, et al. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles. EMBO J. 2017;36:3336\u201355.","journal-title":"EMBO J"},{"key":"1487_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41574-022-00685-4","volume":"18","author":"SR Davis","year":"2022","unstructured":"Davis SR, Baber RJ. Treating menopause - MHT and beyond. Nat Rev Endocrinol. 2022;18:490\u2013502.","journal-title":"Nat Rev Endocrinol"},{"key":"1487_CR18","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1038\/onc.2012.529","volume":"32","author":"G Deblois","year":"2013","unstructured":"Deblois G, St-Pierre J, Gigu\u00e8re V. The PGC-1\/ERR signaling axis in cancer. Oncogene. 2013;32:3483\u201390.","journal-title":"Oncogene"},{"key":"1487_CR19","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","volume":"19","author":"A Dey","year":"2020","unstructured":"Dey A, Varelas X, Guan KL. Targeting the hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020;19:480\u201394.","journal-title":"Nat Rev Drug Discov"},{"key":"1487_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrc3896","volume":"15","author":"EC Dietze","year":"2015","unstructured":"Dietze EC, Sistrunk C, Miranda-Carboni G, O\u2019Regan R, Seewaldt VL. Triple-negative breast cancer in African-American women: disparities versus biology. Nat Rev Cancer. 2015;15:248\u201354.","journal-title":"Nat Rev Cancer"},{"key":"1487_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcancer.2015.09.010","volume":"35","author":"J Dittmer","year":"2015","unstructured":"Dittmer J. The role of the transcription factor Ets1 in carcinoma. Semin Cancer Biol. 2015;35:20\u201338.","journal-title":"Semin Cancer Biol"},{"key":"1487_CR22","doi-asserted-by":"publisher","first-page":"9298","DOI":"10.1158\/0008-5472.CAN-10-0226","volume":"70","author":"MA Dwyer","year":"2010","unstructured":"Dwyer MA, Joseph JD, Wade HE, Eaton ML, Kunder RS, Kazmin D, et al. WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res. 2010;70:9298\u2013308.","journal-title":"Cancer Res"},{"key":"1487_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ceb.2014.11.002","volume":"33","author":"W Fan","year":"2015","unstructured":"Fan W, Evans R. PPARs and ERRs: molecular mediators of mitochondrial metabolism. Curr Opin Cell Biol. 2015;33:49\u201354.","journal-title":"Curr Opin Cell Biol"},{"key":"1487_CR24","doi-asserted-by":"publisher","first-page":"e103209","DOI":"10.15252\/embj.2019103209","volume":"39","author":"N Feldker","year":"2020","unstructured":"Feldker N, Ferrazzi F, Schuhwerk H, Widholz SA, Guenther K, Frisch I, et al. Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer. EMBO J. 2020;39:e103209.","journal-title":"EMBO J"},{"key":"1487_CR25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/bjc.2016.66","volume":"114","author":"SA Fry","year":"2016","unstructured":"Fry SA, Robertson CE, Swann R, Dwek MV. Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion. Br J Cancer. 2016;114:1019\u201326.","journal-title":"Br J Cancer"},{"key":"1487_CR26","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41467-022-29358-6","volume":"13","author":"G Gambardella","year":"2022","unstructured":"Gambardella G, Viscido G, Tumaini B, Isacchi A, Bosotti R, di Bernardo D. A single-cell analysis of breast cancer cell lines to study tumour heterogeneity and drug response. Nat Commun. 2022;13:1714.","journal-title":"Nat Commun"},{"key":"1487_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593\u2013601.","journal-title":"Nat Cell Biol"},{"key":"1487_CR28","first-page":"100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024;5:100625.","journal-title":"Innovation (Camb)"},{"key":"1487_CR29","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1158\/0008-5472.CAN-08-3062","volume":"69","author":"S Heck","year":"2009","unstructured":"Heck S, Rom J, Thewes V, Becker N, Blume B, Sinn HP, et al. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma. Cancer Res. 2009;69:5186\u201393.","journal-title":"Cancer Res"},{"key":"1487_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell. 2019;35:428-440.e5.","journal-title":"Cancer Cell"},{"key":"1487_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.devcel.2013.04.021","volume":"25","author":"LM Koontz","year":"2013","unstructured":"Koontz LM, Liu-Chittenden Y, Yin F, Zheng Y, Yu J, Huang B, et al. The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev Cell. 2013;25:388\u2013401.","journal-title":"Dev Cell"},{"key":"1487_CR32","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1038\/s41467-023-41473-6","volume":"14","author":"B Kumar","year":"2023","unstructured":"Kumar B, Khatpe AS, Guanglong J, Batic K, Bhat-Nakshatri P, Granatir MM, et al. Stromal heterogeneity may explain increased incidence of metaplastic breast cancer in women of African descent. Nat Commun. 2023;14:5683.","journal-title":"Nat Commun"},{"key":"1487_CR33","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121:2750\u201367.","journal-title":"J Clin Invest"},{"key":"1487_CR34","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1038\/ncomms10498","volume":"7","author":"W Lehmann","year":"2016","unstructured":"Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498.","journal-title":"Nat Commun"},{"key":"1487_CR35","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/jcm11051250","volume":"11","author":"A Lepucki","year":"2022","unstructured":"Lepucki A, Orli\u0144ska K, Mielczarek-Palacz A, Kabut J, Olczyk P, Komosi\u0144ska-Vassev K. The role of extracellular matrix proteins in breast cancer. J Clin Med. 2022;11:1250.","journal-title":"J Clin Med"},{"key":"1487_CR36","doi-asserted-by":"crossref","unstructured":"Lin J, Zhang P, Liu W, Liu G, Zhang J, Yan M, et al. A positive feedback loop between ZEB2 and ACSL4 regulates lipid metabolism to promote breast cancer metastasis. Elife. 2023;12:RP87510.","DOI":"10.7554\/eLife.87510.4"},{"key":"1487_CR37","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1210\/me.2008-0282","volume":"23","author":"D Liu","year":"2009","unstructured":"Liu D, Benlhabib H, Mendelson CR. cAMP enhances estrogen-related receptor alpha (ERRalpha) transcriptional activity at the SP-A promoter by increasing its interaction with protein kinase A and steroid receptor coactivator 2 (SRC-2). Mol Endocrinol. 2009;23:772\u201383.","journal-title":"Mol Endocrinol"},{"key":"1487_CR38","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1158\/2159-8290.CD-22-0138","volume":"12","author":"R Martini","year":"2022","unstructured":"Martini R, Delpe P, Chu TR, Arora K, Lord B, Verma A. African ancestry-associated gene expression profiles in triple-negative breast cancer underlie altered tumor biology and clinical outcome in women of African descent. Cancer Discov. 2022;12:2530\u201351.","journal-title":"Cancer Discov"},{"key":"1487_CR39","doi-asserted-by":"publisher","first-page":"686763","DOI":"10.3389\/fmolb.2021.686763","volume":"8","author":"Y Mohamedi","year":"2021","unstructured":"Mohamedi Y, Fontanil T, Cal S, Cobo T, Obaya \u00c1J. ADAMTS-12: functions and challenges for a complex metalloprotease. Front Mol Biosci. 2021;8:686763.","journal-title":"Front Mol Biosci"},{"key":"1487_CR40","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1200\/JCO.2005.03.3472","volume":"24","author":"LA Newman","year":"2006","unstructured":"Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24:1342\u20139.","journal-title":"J Clin Oncol"},{"key":"1487_CR41","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160\u20137.","journal-title":"J Clin Oncol"},{"key":"1487_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265\u201373.","journal-title":"Nat Rev Cancer"},{"key":"1487_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymeth.2019.09.007","volume":"175","author":"C Poulard","year":"2020","unstructured":"Poulard C, Jacquemetton J, Pham TH, Le Romancer M. Using proximity ligation assay to detect protein arginine methylation. Methods. 2020;175:66\u201371.","journal-title":"Methods"},{"key":"1487_CR44","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010;12:R68.","journal-title":"Breast Cancer Res"},{"key":"1487_CR45","doi-asserted-by":"publisher","first-page":"e97115","DOI":"10.15252\/embj.201797115","volume":"37","author":"P Rosmaninho","year":"2018","unstructured":"Rosmaninho P, M\u00fckusch S, Piscopo V, Teixeira V, Raposo AA, Warta R, et al. Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion. EMBO J. 2018;37:e97115.","journal-title":"EMBO J"},{"key":"1487_CR46","doi-asserted-by":"publisher","first-page":"15108","DOI":"10.1073\/pnas.1402094111","volume":"111","author":"J Sailland","year":"2014","unstructured":"Sailland J, Tribollet V, Forcet C, Billon C, Barenton B, Carnesecchi J, et al. Estrogen-related receptor \u03b1 decreases RHOA stability to induce orientated cell migration. Proc Natl Acad Sci U S A. 2014;111:15108\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1487_CR47","doi-asserted-by":"publisher","first-page":"101925","DOI":"10.1016\/j.molmet.2024.101925","volume":"83","author":"C Scholtes","year":"2024","unstructured":"Scholtes C, Dufour CR, Pleynet E, Kamyabiazar S, Hutton P, Baby R, et al. Identification of a chromatin-bound ERR\u03b1 interactome network in mouse liver. Mol Metab. 2024;83:101925.","journal-title":"Mol Metab"},{"key":"1487_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41556-018-0196-y","volume":"21","author":"MP Stemmler","year":"2019","unstructured":"Stemmler MP, Eccles RL, Brabletz S, Brabletz T. Non-redundant functions of EMT transcription factors. Nat Cell Biol. 2019;21:102\u201312.","journal-title":"Nat Cell Biol"},{"key":"1487_CR49","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/s41417-022-00461-6","volume":"29","author":"V Tribollet","year":"2022","unstructured":"Tribollet V, Cerutti C, G\u00e9lo\u00ebn A, Berger E, De Mets R, Balland M, et al. ERR\u03b1 coordinates actin and focal adhesion dynamics. Cancer Gene Ther. 2022;29:1429\u201338.","journal-title":"Cancer Gene Ther"},{"key":"1487_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.matbio.2023.12.003","volume":"125","author":"P Trono","year":"2024","unstructured":"Trono P, Ottavi F, Rosano\u2019 L. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention. Matrix Biol. 2024;125:31\u20139.","journal-title":"Matrix Biol"},{"key":"1487_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41388-023-02899-w","volume":"43","author":"JM Vanacker","year":"2024","unstructured":"Vanacker JM, Forcet C. ERR\u03b1: unraveling its role as a key player in cell migration. Oncogene. 2024;43:379\u201387.","journal-title":"Oncogene"},{"key":"1487_CR52","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1073\/pnas.0607696104","volume":"104","author":"JA Villena","year":"2007","unstructured":"Villena JA, Hock MB, Chang WY, Barcas JE, Gigu\u00e8re V, Kralli A. Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis. Proc Natl Acad Sci U S A. 2007;104:1418\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1487_CR53","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ncb1998","volume":"11","author":"U Wellner","year":"2009","unstructured":"Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009;11:1487\u201395.","journal-title":"Nat Cell Biol"},{"key":"1487_CR54","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fendo.2019.00206","volume":"10","author":"H Xia","year":"2019","unstructured":"Xia H, Dufour CR, Gigu\u00e8re V. ERRalpha as a bridge between transcription and function: role in liver metabolism and disease. Front Endocrinol (Lausanne). 2019;10:206.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1487_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer. 2022;8:95.","journal-title":"NPJ Breast Cancer"},{"key":"1487_CR56","doi-asserted-by":"publisher","first-page":"10041","DOI":"10.1038\/s41598-018-27676-8","volume":"8","author":"L Zhang","year":"2018","unstructured":"Zhang L, Carnesecchi J, Cerutti C, Tribollet V, P\u00e9rian S, Forcet C, et al. LSD1-ERR\u03b1 complex requires NRF1 to positively regulate transcription and cell invasion. Sci Rep. 2018a;8:10041.","journal-title":"Sci Rep"},{"key":"1487_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2018.05.004","volume":"429","author":"YY Zhang","year":"2018","unstructured":"Zhang YY, Kong LQ, Zhu XD, Cai H, Wang CH, Shi WK, et al. CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway. Cancer Lett. 2018b;429:29\u201340.","journal-title":"Cancer Lett"},{"key":"1487_CR58","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1038\/s41388-020-01514-6","volume":"39","author":"X Zheng","year":"2020","unstructured":"Zheng X, Lu S, He Z, Huang H, Yao Z, Miao Y, et al. MCU-dependent negative sorting of miR-4488 to extracellular vesicles enhances angiogenesis and promotes breast cancer metastatic colonization. Oncogene. 2020;39:6975\u201389.","journal-title":"Oncogene"},{"key":"1487_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/path.4329","volume":"233","author":"C Zou","year":"2014","unstructured":"Zou C, Yu S, Xu Z, Wu D, Ng CF, Yao X, et al. ERR\u03b1 augments HIF-1 signalling by directly interacting with HIF-1\u03b1 in normoxic and hypoxic prostate cancer cells. J Pathol. 2014;233:61\u201373.","journal-title":"J Pathol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01487-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01487-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01487-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:18:43Z","timestamp":1782872323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01487-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01487-4","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"OT received honoraria for lectures, presentations, and advisory board from Roche, Pfizer, Novartis-Sandoz, Lilly, MSD, Astra-Zeneca, Pierre Fabre, Seagen, Daiichi-Sankyo, Gilead, Eisai, Menarini-Stemline, Veracyte and Exact Sciences. Funders had no role in the design of the study, collection and analysis of data and decision to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}